Michael S. Mega, M.D., Ph.D., focuses on cognitive neurology: disorders of memory, language, visuospatial processing and problem solving.
In addition to working with patients who have already been diagnosed with an early dementia, Dr. Mega sees people who seem normal but are worried that their memory is worse than others their age. “Alzheimer’s disease affects the brain up to two decades before people start noticing signs such as forgetfulness,” he says. “So it’s important to start intervening in the disease as early as possible.”
Dr. Mega anticipates taking part in two important clinical trials that are about to get under way nationwide. The first involves disease-modifying drugs that help slow the progression of Alzheimer’s disease. The second trial involves the use of a skin patch, designed to increase medication compliance for those suffering from Alzheimer’s disease.
Dr. Mega received his medical degree at George Washington University. He completed his neurology residency at Boston University, a research fellowship in neurobehavior at UCLA, and a Ph.D. in neuroscience at UCLA.
Clinical articlesCould new therapies slow or even stop Alzheimer’s disease?PubMed listingsFeaturedResearch links contact sports to brain damage, KGW-TVResearch stories: What if? Providence Together magazine
Could new therapies slow or even stop Alzheimer's disease?
Research stories: What if?